{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:01:37Z","timestamp":1792648897330,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009389","name":"Stiftelsen Promobilia","doi-asserted-by":"publisher","award":["21500"],"award-info":[{"award-number":["21500"]}],"id":[{"id":"10.13039\/100009389","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003849","name":"IngaBritt och Arne Lundbergs Forskningsstiftelse","doi-asserted-by":"publisher","award":["2020-0"],"award-info":[{"award-number":["2020-0"]}],"id":[{"id":"10.13039\/501100003849","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2020-04817"],"award-info":[{"award-number":["2020-04817"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002835","name":"Chalmers University of Technology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002835","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Painful conditions such as residual limb pain (RLP) and phantom limb pain (PLP) can manifest after amputation. The mechanisms underlying such postamputation pains are diverse and should be addressed accordingly. Different surgical treatment methods have shown potential for alleviating RLP due to neuroma formation\u00a0\u2014\u00a0commonly known as neuroma pain\u00a0\u2014\u00a0and to a lesser degree PLP. Two reconstructive surgical interventions, namely targeted muscle reinnervation (TMR) and regenerative peripheral nerve interface (RPNI), are gaining popularity in postamputation pain treatment with promising results. However, these two methods have not been directly compared in a randomised controlled trial (RCT). Here, we present a study protocol for an international, double-blind, RCT to assess the effectiveness of TMR, RPNI, and a non-reconstructive procedure called neuroma transposition (active control) in alleviating RLP, neuroma pain, and PLP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>One hundred ten upper and lower limb amputees suffering from RLP will be recruited and assigned randomly to one of the surgical interventions (TMR, RPNI, or neuroma transposition) in an equal allocation ratio. Complete evaluations will be performed during a baseline period prior to the surgical intervention, and follow-ups will be conducted in short term (1, 3, 6, and 12\u00a0months post-surgery) and in long term (2 and 4\u00a0years post-surgery). After the 12-month follow-up, the study will be unblinded for the evaluator and the participants. If the participant is unsatisfied with the outcome of the treatment at that time, further treatment including one of the other procedures will be discussed in consultation with the clinical investigator at that site.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>A double-blind RCT is necessary for the establishment of evidence-based procedures, hence the motivation for this work. In addition, studies on pain are challenging due to the subjectivity of the experience and the lack of objective evaluation methods. Here, we mitigate this problem by including different pain evaluation methods known to have clinical relevance. We plan to analyse the primary variable, mean change in NRS (0\u201310) between baseline and the 12-month follow-up, using the intention-to-treat (ITT) approach to minimise bias and keep the advantage of randomisation. The secondary outcomes will be analysed on both ITT and per-protocol (PP). An adherence protocol (PP population) analysis will be used for estimating a more realistic effect of treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov NCT05009394.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-023-07286-0","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T09:02:33Z","timestamp":1683018153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Surgical treatments for postamputation pain: study protocol for an international, double-blind, randomised controlled trial"],"prefix":"10.1186","volume":"24","author":[{"given":"Emily","family":"Pettersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Sassu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Reinholdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Dahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Rolfson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Bj\u00f6rkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Innocenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Alice","family":"Pedrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Breyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adil","family":"Ladak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hollie","family":"Power","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6084-3865","authenticated-orcid":false,"given":"Max","family":"Ortiz-Catalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,2]]},"reference":[{"key":"7286_CR1","first-page":"121","volume":"6","author":"E Hsu","year":"2013","unstructured":"Hsu E, Cohen SP. Postamputation pain: epidemiology, mechanisms, and treatment. J Pain Res Dove Press. 2013;6:121\u201336.","journal-title":"J Pain Res Dove Press"},{"key":"7286_CR2","doi-asserted-by":"publisher","unstructured":"Limakatso K, Bedwell GJ, Madden VJ, Parker R. The prevalence and risk factors for phantom limb pain in people with amputations: A systematic review and meta-analysis. PLoS ONE. 2020;15(10):e0240431. https:\/\/doi.org\/10.1371\/journal.pone.0240431.","DOI":"10.1371\/journal.pone.0240431"},{"issue":"1","key":"7286_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/j.pain.0000000000001413","volume":"160","author":"SA Schug","year":"2019","unstructured":"Schug SA, Lavand P, Barke A, Korwisi B, Rief W. The IASP classification of chronic pain for ICD-11: chronic postsurgical or posttraumatic. Pain. 2019;160(1):45\u201352.","journal-title":"Pain."},{"key":"7286_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2018.00748\/full","volume":"9","author":"M Ortiz-Catalan","year":"2018","unstructured":"Ortiz-Catalan M. The stochastic entanglement and phantom motor execution hypotheses: a theoretical framework for the origin and treatment of phantom limb pain. Front Neurol. 2018;9:1\u201316. https:\/\/doi.org\/10.3389\/fneur.2018.00748\/full.","journal-title":"Front Neurol."},{"key":"7286_CR5","doi-asserted-by":"crossref","unstructured":"Lee M, Guyuron B. Postoperative neuromas. Nerves Nerve Inj. Elsevier Ltd.; 2015.","DOI":"10.1016\/B978-0-12-802653-3.00056-7"},{"key":"7286_CR6","unstructured":"International Association for the Study of Pain. IASP global year against neuropathic pain 2014\u20132015, postamputation pain. 2014 [cited 2022 Nov 28]. p. 2. Available from: https:\/\/www.aped-dor.org\/images\/FactSheets\/DorNeuropatica\/en\/Postamputation_Pain.pdf"},{"key":"7286_CR7","doi-asserted-by":"publisher","unstructured":"Kuiken T, Feuser A, Barlow A. Targeted muscle reinnervation. Taylor & Francis; 2013 [cited 2015 Jan 7]. Available from: http:\/\/www.crcnetbase.com\/doi\/book\/https:\/\/doi.org\/10.1201\/b15079","DOI":"10.1201\/b15079"},{"key":"7286_CR8","first-page":"79","volume":"74","author":"RW Davis","year":"1993","unstructured":"Davis RW. Phantom sensation, phantom pain, and stump pain. Arch Phys Med Rehabil. 1993;74:79\u201391.","journal-title":"Arch Phys Med Rehabil."},{"key":"7286_CR9","doi-asserted-by":"crossref","unstructured":"Sherman RA, Sherman CJ, Gall NG. A survey of current phantom limb pain treatment in the United States. Pain [Internet]. 1980;8:85\u201399. Available from: http:\/\/content.wkhealth.com\/linkback\/openurl?sid=WKPTLP:landingpage&an=00006396-198002000-00008","DOI":"10.1016\/0304-3959(80)90092-5"},{"key":"7286_CR10","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/micr.30575","volume":"40","author":"AL Dellon","year":"2020","unstructured":"Dellon AL, Aszmann OC. In musculus, veritas? Nerve \u201cin muscle\u201d versus targeted muscle reinnervation versus regenerative peripheral nerve interface: historical review. Microsurgery. 2020;40:516\u201322. https:\/\/doi.org\/10.1002\/micr.30575.","journal-title":"Microsurgery."},{"key":"7286_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s40141-020-00276-2","volume":"8","author":"SE Hart","year":"2020","unstructured":"Hart SE, Kung TA. Novel approaches to reduce symptomatic neuroma pain after limb amputation. Curr Phys Med Rehabil Reports Springer. 2020;8:83\u201391.","journal-title":"Curr Phys Med Rehabil Reports Springer"},{"key":"7286_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/SLA.0000000000003088","volume":"270","author":"GA Dumanian","year":"2019","unstructured":"Dumanian GA, Potter BK, Mioton LM, Ko JH, Cheesborough JE, Souza JM, et al. Targeted muscle reinnervation treats neuroma and phantom pain in major limb amputees: a randomized clinical trial. Ann Surg. 2019;270:238\u201346.","journal-title":"Ann Surg"},{"key":"7286_CR13","doi-asserted-by":"publisher","first-page":"e1038","DOI":"10.1097\/GOX.0000000000001038","volume":"4","author":"SL Woo","year":"2016","unstructured":"Woo SL, Kung TA, Brown DL, Leonard JA, Kelly BM, Cederna PS. Regenerative peripheral nerve interfaces for the treatment of postamputation neuroma pain. Plast Reconstr Surg - Glob Open. 2016;4:e1038. Available from: http:\/\/insights.ovid.com\/crossref?an=01720096-201612000-00006.","journal-title":"Plast Reconstr Surg - Glob Open."},{"key":"7286_CR14","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1001\/jamasurg.2018.0864","volume":"153","author":"CA Kubiak","year":"2018","unstructured":"Kubiak CA, Kemp SWP, Cederna PS. Regenerative peripheral nerve interface for management of postamputation neuroma. JAMA Surg Am Med Assoc. 2018;153:681\u20132.","journal-title":"JAMA Surg Am Med Assoc"},{"key":"7286_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0006-8993(95)00102-V","volume":"676","author":"TA Kuiken","year":"1995","unstructured":"Kuiken TA, Childress DS, Zev RW. The hyper-reinnervation of rat skeletal muscle. Brain Res Elsevier. 1995;676:113\u201323.","journal-title":"Brain Res Elsevier"},{"key":"7286_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3109\/03093640409167756","volume":"28","author":"T Kuiken","year":"2004","unstructured":"Kuiken T, Dumanian G, Lipschutz R, Miller LA, Stubblefield K. The use of targeted muscle reinnervation for improved myoelectric prosthesis control in a bilateral shoulder disarticulation amputee. Prosthet Orthot Int. 2004;28:245\u201353. Informa UK Ltd UK.","journal-title":"Prosthet Orthot Int."},{"key":"7286_CR17","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1007\/s11999-014-3528-7","volume":"472","author":"JM Souza","year":"2014","unstructured":"Souza JM, Cheesborough JE, Ko JH, Cho MS, Kuiken TA, Dumanian GA. Targeted muscle reinnervation: a novel approach to postamputation neuroma pain. Clin Orthop Relat Res. 2014;472:2984\u201390. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24562875.","journal-title":"Clin Orthop Relat Res."},{"key":"7286_CR18","doi-asserted-by":"publisher","first-page":"651e","DOI":"10.1097\/PRS.0000000000007235","volume":"146","author":"ST Lanier","year":"2020","unstructured":"Lanier ST, Jordan SW, Ko JH, Dumanian GA. Targeted muscle reinnervation as a solution for nerve pain. Plast Reconstr Surg. 2020;146:651e\u201363e. https:\/\/doi.org\/10.1097\/PRS.0000000000007235.","journal-title":"Plast Reconstr Surg."},{"key":"7286_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cps.2020.01.004","volume-title":"Regenerative peripheral nerve interfaces for prevention and management of neuromas","author":"KB Santosa","year":"2020","unstructured":"Santosa KB, Oliver JD, Cederna PS, Kung TA. Regenerative peripheral nerve interfaces for prevention and management of neuromas. Clin Plast Surg: Elsevier Inc; 2020."},{"key":"7286_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0304-3959(87)91074-8","volume":"30","author":"R Melzack","year":"1987","unstructured":"Melzack R. The Short-form McGill Pain Questionnaire. Pain. 1987;30:191\u20137.","journal-title":"Pain"},{"key":"7286_CR21","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1016\/S0140-6736(16)31598-7","volume":"388","author":"M Ortiz-Catalan","year":"2016","unstructured":"Ortiz-Catalan M, Gu\u00f0mundsd\u00f3ttir RA, Kristoffersen MB, Zepeda-Echavarria A, Caine-Winterberger K, Kulbacka-Ortiz K, et al. Phantom motor execution facilitated by machine learning and augmented reality as treatment for phantom limb pain: a single group, clinical trial in patients with chronic intractable phantom limb pain. Lancet. 2016;388:2885\u201394. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27916234.","journal-title":"Lancet."},{"key":"7286_CR22","doi-asserted-by":"publisher","first-page":"974","DOI":"10.2466\/pms.1984.59.3.974","volume":"59","author":"CA Pollard","year":"1984","unstructured":"Pollard CA. Preliminary validity study of the Pain Disability Index. Percept Mot Skills. 1984;59:974. SAGE PublicationsSage CA: Los Angeles, CA.","journal-title":"Percept Mot Skills."},{"key":"7286_CR23","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727\u201336.","journal-title":"Qual Life Res"},{"key":"7286_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejpain.2005.12.008","volume":"11","author":"MK Nicholas","year":"2007","unstructured":"Nicholas MK. The pain self-efficacy questionnaire: taking pain into account. Eur J Pain Eur J Pain. 2007;11:153\u201363.","journal-title":"Eur J Pain Eur J Pain"},{"key":"7286_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jpain.2014.11.002","volume":"16","author":"M Nicholas","year":"2015","unstructured":"Nicholas M, McGuire B, Asghari A. A 2-item short form of the pain self-efficacy questionnaire: development and psychometric evaluation of PSEQ-2. J Pain. 2015;16:153\u201363. Churchill Livingstone Inc.","journal-title":"J Pain"},{"key":"7286_CR26","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1037\/1040-3590.7.4.524","volume":"7","author":"MJL Sullivan","year":"1995","unstructured":"Sullivan MJL, Bishop SR, Pivik J. The Pain Catastrophizing Scale: development and validation. Psychol Assess. 1995;7:524\u201332.","journal-title":"Psychol Assess"},{"key":"7286_CR27","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/ejp.665","volume":"19","author":"LA McWilliams","year":"2015","unstructured":"McWilliams LA, Kowal J, Wilson KG. Development and evaluation of short forms of the Pain Catastrophizing Scale and the Pain Self-efficacy Questionnaire. Eur J Pain. 2015;19:1342\u20139. Blackwell Publishing Ltd.","journal-title":"Eur J Pain"},{"key":"7286_CR28","doi-asserted-by":"publisher","first-page":"e021039","DOI":"10.1136\/bmjopen-2017-021039","volume":"8","author":"E Lendaro","year":"2018","unstructured":"Lendaro E, Hermansson L, Burger H, Van der Sluis CK, McGuire BE, Pilch M, et al. Phantom motor execution as a treatment for phantom limb pain: protocol of an international, double-blind, randomised controlled clinical trial. BMJ Open. 2018;8:e021039. https:\/\/doi.org\/10.1136\/bmjopen-2017-021039.","journal-title":"BMJ Open"},{"issue":"1","key":"7286_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/00002508-200103000-00008","volume":"17","author":"MJL Sullivan","year":"2001","unstructured":"Sullivan MJL, Thorn B, Haythornthwaite JA, Keefe F, Martin M, Bradley LA, et al. Theoretical perspectives on the relation between catastrophizing and pain. Clin J Pain. 2001;17(1):52\u201364. Lippincott Williams and Wilkins.","journal-title":"Clin J Pain."},{"key":"7286_CR30","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1089\/acm.2016.0242","volume":"22","author":"SMW Jones","year":"2016","unstructured":"Jones SMW, Lange J, Turner J, Cherkin D, Ritenbaugh C, Hsu C, et al. Development and Validation of the EXPECT Questionnaire: assessing patient expectations of outcomes of complementary and alternative medicine treatments for chronic pain. J Altern Complement Med. 2016;22:936\u201346. Mary Ann Liebert Inc.","journal-title":"J Altern Complement Med."},{"issue":"4","key":"7286_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/15424065.2016.1259026","volume":"13","author":"A Wright","year":"2016","unstructured":"Wright A. REDCap: A Tool for the Electronic Capture of Research Data. J Electron Resour Med Libr. 2016;13:(4):197\u2013201. https:\/\/doi.org\/10.1080\/15424065.2016.1259026.","journal-title":"J Electron Resour Med Libr"}],"updated-by":[{"DOI":"10.1186\/s13063-023-07626-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000}}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07286-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07286-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07286-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T10:39:24Z","timestamp":1700476764000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07286-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7286"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07286-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1344117\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,2]]},"assertion":[{"value":"9 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13063-023-07626-0","URL":"https:\/\/doi.org\/10.1186\/s13063-023-07626-0","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This clinical trial was approved by the Swedish Ethics Review Authority, Etikpr\u00f6vningsmyndigheten, on 30 June 2021 with the application number 2021\u201302346. Written, informed consent to participate will be obtained from all participants. Participants in this trial are insured by government insurances in each country: Sweden, Italy, Canada, Chile,\u00a0Australia, UK, and USA. Important protocol modifications will be notified to the ethical committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate."}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"304"}}